Cleared Traditional

K092911 - SMART HBA1C ASSAY KIT

K092911 is an FDA 510(k) clearance for SMART HBA1C ASSAY KIT, manufactured by Diazyme Laboratories. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 216-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
216d
Days
Class 1
Risk

K092911 is an FDA 510(k) clearance for the SMART HBA1C ASSAY KIT, MODEL DZ168B-POC, SMART HBA1C ASSAY CONTROL KIT, MODEL.... Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Diazyme Laboratories (Poway, US). The FDA issued a Cleared decision on April 26, 2010 after a review of 216 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diazyme Laboratories devices

FDA 510(k) Submission Details - K092911

510(k) Number K092911 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2009
Decision Date April 26, 2010
Days to Decision 216 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
128d slower than avg
Panel avg: 88d · This submission: 216d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 403
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K092911.
ELECSYS INSULIN CALCHECK 5
K101075 · Roche Diagnostics Corp. · Jun 2010
AUDIT MICROCV ASO LINEARITY SET, MODEL K721M-5
K100750 · Aalto Scientific, Ltd. · May 2010
ELECSYS FOLATE III CALCHECK 5
K094031 · Roche Diagnostics · Apr 2010
ELECSYS C-PEPTIDE CALCHECK 5
K100810 · Roche Diagnostics · Apr 2010
ELECSYS TSH CALCHECK 5
K093836 · Roche Diagnostics · Apr 2010
CONTREX PLUS LOW CONTROL SOLUTION
K100747 · Apex BioTechnology Corp. · Apr 2010